Frequently asked questions

At the end of the 7-day trial your card is charged at the rate of the plan you selected — $59.99/month or $599/year. You will receive an email reminder before the charge. If you cancel before the trial ends, you will not be charged.

Yes. Cancel from your account dashboard at any time. There are no cancellation fees and no questions asked. Once cancelled, access continues until the end of your current billing period.

Subscriptions are non-refundable except as required by applicable law. If you have a billing issue, email [email protected] and we will review it.

Payments are processed securely through Stripe. All major credit and debit cards are accepted including Visa, Mastercard, and American Express.

Yes. The annual plan is $599/year — equivalent to $49.92/month — saving about $120 compared to monthly billing. All paid plans include a 7-day free trial.

Equity Rank is a research tool for individual investors. It computes fair value estimates for 3,000+ stocks using 19 distinct valuation models (DCF, Graham Number, P/FCF, EV/FCF, EPV, and more; 8–15 run per security depending on data availability), then combines them into a composite S·A·V·E score. The platform is for informational and educational use only — it is not financial advice.

The S·A·V·E score reflects four pillars: Sentiment, Analyst consensus, Valuation, and Earnings quality. It is a composite score from 0 to 100 that aggregates signals across all valuation models. A higher score may correspond to potential undervaluation relative to fair value estimates. It is a research signal, not a guarantee of future performance.

Fair value is a model-derived estimate of intrinsic worth based on publicly available financial data. The platform computes a median fair value across multiple models. Fair value estimates are algorithmic outputs — they may be materially incorrect and should not be treated as price targets.

No. Equity Rank provides data, analysis, and AI-generated commentary for informational and educational purposes only. Nothing on this platform constitutes investment advice or a recommendation to overweight or underweight any security. Equity Rank is not a registered investment adviser. Always consult a licensed financial advisor before making investment decisions.

The Innovation score evaluates a company's research and development investment, patent activity, and forward-looking growth indicators. It is one component of the broader S·A·V·E composite. Like all scores on the platform, it is a research signal derived from publicly available data.

S·A·V·E scores and fair value estimates are recomputed daily. Intraday prices are refreshed throughout the trading day. Financial statement data (used in valuation models) updates when companies report earnings or file with the SEC — typically quarterly.

Equity Rank sources data from Alpha Vantage and FRED (Federal Reserve Economic Data). Financial statement data is derived from SEC filings. Options data is sourced separately for the options analysis features.

AI analysis generates an institutional-depth research note for a given stock covering valuation context, earnings quality, balance sheet health, and risk factors. Notes are generated using the S·A·V·E model outputs and the company's financial data. AI analysis is capped at 50 analyses per week on the Pro plan.

Options analysis surfaces implied volatility rank (IV rank), key Greeks (delta, gamma, theta), and earnings play context for covered stocks. It is intended to provide context for existing options research — not as a trading signal.

The platform covers 3,000+ stocks spanning major US exchanges. The screener includes pre-computed margin of safety percentages for common stocks; preferred shares and closed-end funds are not assigned a fair value, as the common-equity valuation model does not apply to those instrument types. OTC-listed stocks may have reduced data availability.

Without an account: the free screener demo (up to 10 results across three pre-built screens — Undervalued Tech, Dividend Quality, High-IV Earnings) on live data, the public AAPL stock demo page, and the 16 standalone calculator tools (DCF, Graham Number, intrinsic value, and more). With a free account: a 14-day full-access preview, then the Free plan — 3 full valuation reports per month, a top-10 screener preview, one watchlist of up to 10 tickers, and the weekly update email. The full screener — all 3,000+ stocks, every column, 19-method valuation, options, and AI analysis — requires a paid plan.

Full access to all 19 valuation models, AI analysis (50/week), options analysis, fair value detail pages for all 3,000+ stocks, price alerts, and a watchlist of up to 20 stocks all require an active Pro subscription.

No. Creating an account takes no card and gives you a 14-day full-access preview, after which the account settles onto the Free plan. A card is only needed if you choose a paid plan — that route uses a 7-day trial, is not charged until the trial ends, and can be cancelled before then without any cost.

Yes. When the 14-day full-access preview ends, the account moves to the Free plan rather than being locked out. The Free plan includes 3 full valuation reports per month with the complete SAVE score and fair value breakdown, a top-10 preview of the weekly screener, one watchlist of up to 10 tickers, and the weekly update email. It requires no card and does not expire. The full screener, options tools, and AI analysis require a paid plan.